In last trading session, Structure Therapeutics Inc ADR (NASDAQ:GPCR) saw 1.3 million shares changing hands with its beta currently measuring -1.87. Company’s recent per share price level of $23.82 trading at -$0.07 or -0.31% at ring of the bell on the day assigns it a market valuation of $1.37B. That closing price of GPCR’s stock is at a discount of -163.39% from its 52-week high price of $62.74 and is indicating a premium of 44.5% from its 52-week low price of $13.22. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.78 million shares which gives us an average trading volume of 964.91K if we extend that period to 3-months.
For Structure Therapeutics Inc ADR (GPCR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Structure Therapeutics Inc ADR (NASDAQ:GPCR) trade information
Upright in the red during last session for losing -0.31%, in the last five days GPCR remained trading in the red while hitting it’s week-highest on Thursday, 05/08/25 when the stock touched $23.82 price level, adding 13.38% to its value on the day. Structure Therapeutics Inc ADR’s shares saw a change of -12.19% in year-to-date performance and have moved -10.47% in past 5-day. Structure Therapeutics Inc ADR (NASDAQ:GPCR) showed a performance of 25.67% in past 30-days. Number of shares sold short was 7.02 million shares which calculate 7.91 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 93 to the stock, which implies a rise of 74.39% to its current value. Analysts have been projecting 65 as a low price target for the stock while placing it at a high target of 118. It follows that stock’s current price would drop -172.88% in reaching the projected high whereas dropping to the targeted low would mean a loss of -172.88% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -51.75% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -8.70% while estimates for its earnings growth in next 5 years are of -29.12%.
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s Major holders
Insiders are in possession of 2.74% of company’s total shares while institution are holding 108.70 percent of that, with stock having share float percentage of 111.76%. Investors also watch the number of corporate investors in a company very closely, which is 108.70% institutions for Structure Therapeutics Inc ADR that are currently holding shares of the company. WELLINGTON MANAGEMENT GROUP LLP is the top institutional holder at GPCR for having 7.55 million shares of worth $296.41 million. And as of 2024-06-30, it was holding 1.7124 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 5.74 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.3033 of outstanding shares, having a total worth of $225.6 million.
On the other hand, VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and SMALLCAP WORLD FUND INC are the top two Mutual Funds which own company’s shares. As of Jan 31, 2025 , the former fund manager was holding 4.25 shares of worth $101.19 million or 7.41% of the total outstanding shares. The later fund manager was in possession of 3.66 shares on Mar 31, 2025 , making its stake of worth around $87.07 million in the company or a holder of 6.38% of company’s stock.
